SKU(재고 관리 코드):PAA259Hu01
Polyclonal Antibody to Annexin V (ANXA5)
Polyclonal Antibody to Annexin V (ANXA5)
;Immunohistochemistry: 5-20µg/mL;
;Immunocytochemistry: 5-20µg/mL;
;Optimal working dilutions must be determined by end user.
Product No.
PAA259Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPA259Hu01-Recombinant Annexin V (ANXA5)
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
0.33mg/ml
Organism Species More
Mus musculus (Mouse), Rattus norvegicus (Rat), Capra hircus; Caprine (Goat), Ovis aries; Ovine (Sheep)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against ANXA5. It has been selected for its ability to recognize ANXA5 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine | Citations |
Molecular Biology | Markers of apoptotic dysfunctions in schizophrenia Pubmed: 24466757 |
Neuroscience and Behavioral Physiology | Involvement of Anomalous Apoptosis in Impairments to Synaptic Plasticity in Post-Traumatic Stress Disorder Springer: Source |
Inflammation and Cell Signaling | Collectins, C3 complement protein, annexin V and C-reactive protein in acute ischemic stroke: interrelation and implication to upregulated apoptosis and inflammation Smartscitech: Source |
Lung | Annexin A5 Protein as a Potential Biomarker for the Diagnosis of Asthma Pubmed: 30182154 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA259Hu04 | Recombinant Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA259Hu01 | Recombinant Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA259Hu05 | Recombinant Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA259Hu61 | Eukaryotic Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
APA259Hu61 | Active Annexin V (ANXA5) | Cell culture; Activity Assays. |
RPA259Hu06 | Recombinant Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA259Hu03 | Recombinant Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA259Hu02 | Recombinant Annexin V (ANXA5) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA259Hu01 | Polyclonal Antibody to Annexin V (ANXA5) | WB; IHC; ICC; IP. |
LAA259Hu71 | Biotin-Linked Polyclonal Antibody to Annexin V (ANXA5) | WB; IHC; ICC. |
LAA259Hu81 | FITC-Linked Polyclonal Antibody to Annexin V (ANXA5) | WB; IHC; ICC; IF. |
MAA259Hu21 | Monoclonal Antibody to Annexin V (ANXA5) | WB; IHC; ICC; IP. |
MAA259Hu22 | Monoclonal Antibody to Annexin V (ANXA5) | WB,IHC |
FAA259Hu02 | Anti-Annexin V (ANXA5) Monoclonal Antibody | FCM |
LAA259Hu82 | FITC-Linked Monoclonal Antibody to Annexin V (ANXA5) | WB; IHC; ICC; IF. |
LAA259Hu72 | Biotin-Linked Monoclonal Antibody to Annexin V (ANXA5) | WB; IHC; ICC. |
FAA259Hu82 | FITC-Linked Anti-Annexin V (ANXA5) Monoclonal Antibody | FCM |
SEA259Hu | ELISA Kit for Annexin V (ANXA5) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA259Hu | Magnetic Luminex Assay Kit for Annexin V (ANXA5) ,etc. | Magnetic Luminex Assay for Antigen Detection. |